Related Experiment Video
Updated: Mar 26, 2026

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Ferroptosis: process and function
1Department of Surgery, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA.
Abstract:
Ferroptosis is a recently recognized form of regulated cell death. It is characterized morphologically by the presence of smaller than normal mitochondria with condensed mitochondrial membrane densities, reduction or vanishing of mitochondria crista, and outer mitochondrial membrane rupture. It can be induced by experimental compounds (e.g., erastin, Ras-selective lethal small molecule 3, and buthionine sulfoximine) or clinical drugs (e.g., sulfasalazine, sorafenib, and artesunate) in cancer cells and certain normal cells (e.g., kidney tubule cells, neurons, fibroblasts, and T cells). Activation of mitochondrial voltage-dependent anion channels and mitogen-activated protein kinases, upregulation of endoplasmic reticulum stress, and inhibition of cystine/glutamate antiporter is involved in the induction of ferroptosis. This process is characterized by the accumulation of lipid peroxidation products and lethal reactive oxygen species (ROS) derived from iron metabolism and can be pharmacologically inhibited by iron chelators (e.g., deferoxamine and desferrioxamine mesylate) and lipid peroxidation inhibitors (e.g., ferrostatin, liproxstatin, and zileuton). Glutathione peroxidase 4, heat shock protein beta-1, and nuclear factor erythroid 2-related factor 2 function as negative regulators of ferroptosis by limiting ROS production and reducing cellular iron uptake, respectively. In contrast, NADPH oxidase and p53 (especially acetylation-defective mutant p53) act as positive regulators of ferroptosis by promotion of ROS production and inhibition of expression of SLC7A11 (a specific light-chain subunit of the cystine/glutamate antiporter), respectively. Misregulated ferroptosis has been implicated in multiple physiological and pathological processes, including cancer cell death, neurotoxicity, neurodegenerative diseases, acute renal failure, drug-induced hepatotoxicity, hepatic and heart ischemia/reperfusion injury, and T-cell immunity. In this review, we summarize the regulation mechanisms and signaling pathways of ferroptosis and discuss the role of ferroptosis in disease.
Insights
Ferroptosis, a regulated cell death, involves iron metabolism and lipid peroxidation. Understanding its mechanisms and regulators is key to addressing diseases like cancer and neurodegeneration.
Area of Science:
- Cell Biology
- Biochemistry
- Pathology
Background:
- Ferroptosis is a distinct form of regulated cell death characterized by specific mitochondrial and biochemical alterations.
- It is implicated in various physiological and pathological conditions, including cancer and neurodegenerative diseases.
Purpose of the Study:
- To review the molecular mechanisms and signaling pathways governing ferroptosis.
- To discuss the multifaceted role of ferroptosis in diverse disease contexts.
Main Methods:
- Literature review of ferroptosis research.
- Analysis of molecular regulators and signaling pathways involved in ferroptosis induction and inhibition.
Main Results:
- Ferroptosis is induced by factors affecting mitochondrial function, iron metabolism, and lipid peroxidation, involving pathways like the cystine/glutamate antiporter.
- Key regulators include glutathione peroxidase 4, NADPH oxidase, and p53, influencing reactive oxygen species (ROS) production and iron uptake.
- Pharmacological interventions targeting iron chelation and lipid peroxidation can inhibit ferroptosis.
Conclusions:
- Ferroptosis is a complex process with significant implications for human health and disease.
- Further research into ferroptosis regulation holds therapeutic potential for conditions ranging from cancer to organ injury.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
The Early Endosome: Endocytosis of Transferrin
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
